News from cell therapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Feb 09, 2015, 07:15 ET
BrainStorm Cell Therapeutics

BrainStorm Receives Notice of Allowance for its NurOwn™ Technology Platform from Israel's Patent Office

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Feb 04, 2015, 07:05 ET
BrainStorm Cell Therapeutics

BrainStorm CEO to Present at the 17th Annual BIO CEO & Investor Conference

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Feb 03, 2015, 08:16 ET
BrainStorm Cell Therapeutics

BrainStorm Announces Positive DSMB Recommendation in Ongoing Phase 2 Trial with NurOwn™ in ALS

 BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases,...

Jan 26, 2015, 07:05 ET
BrainStorm Cell Therapeutics

BrainStorm Announces Exceptional Preclinical Results of NurOwn™ in Mouse Autism Model

 BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Jan 08, 2015, 09:43 ET
BrainStorm Cell Therapeutics

BrainStorm Enters Into Warrant Exercise Agreement for Approximately $13 Million in Proceeds

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Jan 07, 2015, 08:22 ET
BrainStorm Cell Therapeutics

BrainStorm Announces Receipt of Approximately $3.1 Million from Warrant Exercises

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Jan 06, 2015, 07:05 ET
BrainStorm Cell Therapeutics

BrainStorm CEO to Present at Two Upcoming Investor Conferences

 BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Jan 05, 2015, 08:20 ET
BrainStorm Cell Therapeutics

BrainStorm Announces Final Analysis of Phase 2a ALS Study Showing Nearly All Subjects Experienced Clinical Benefit from NurOwn™

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Dec 22, 2014, 10:45 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics to Host Conference Call to Discuss Final Results of Phase 2a Trial of NurOwn™ in ALS on January 5, 2015

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, will...

Dec 15, 2014, 06:45 ET
BrainStorm Cell Therapeutics

BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases,...

Nov 13, 2014, 07:13 ET
BrainStorm Cell Therapeutics

BrainStorm Announces Financial Results for the Third Quarter of 2014 and Provides Corporate Update

 BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced...

Nov 05, 2014, 08:45 ET

BrainStorm Cell Therapeutics to Report Third Quarter 2014 Financial Results on Thursday, November 13

 BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today...

Oct 07, 2014, 07:07 ET
BrainStorm Cell Therapeutics (PRNewsFoto/BrainStorm Cell Therapeutics Inc)

FDA Grants Fast Track Designation to NurOwn™ for the Treatment of ALS

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases,...

Oct 06, 2014, 09:00 ET

BrainStorm Reports Last Patient Visit in Phase 2a ALS Study

BrainStorm Cell Therapeutics (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced...

May 30, 2014, 01:30 ET
CTI BioPharma Corp. Logo (PRNewsFoto/Cell Therapeutics, Inc.)

Cell Therapeutics, Inc. Announces Change of Name to CTI BioPharma Corp.

 Cell Therapeutics, Inc. (CTI or the Company) (NASDAQ and MTA: CTIC), a biopharmaceutical company focused on acquiring, developing and bringing...

May 29, 2014, 01:30 ET

Cell Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference

Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today that management will present at the Jefferies 2014 Global Healthcare...

Apr 29, 2014, 16:01 ET

Cell Therapeutics Reports First Quarter 2014 Financial Results

Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported financial results for the first quarter ended March 31, 2014. "In the first...

Apr 29, 2014, 01:30 ET

PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

 Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the launch of PIXUVRI® (pixantrone), the first new treatment for...

Apr 22, 2014, 01:30 ET

Cell Therapeutics to Report First Quarter 2014 Financial Results on April 29, 2014

 Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today that it will report its first quarter 2014 financial results on Tuesday,...

Mar 05, 2014, 01:30 ET

Cell Therapeutics to Present at the 26th Annual ROTH Conference

 Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today that management will present at the ROTH Capital Partners 26th Annual...